CancerFax

EDGE non-invasive tumor radiosurgery for lung cancer

Sai SreeWritten by Sai SreeMedically ReviewedUpdated April 10, 20205 min read
EDGE non-invasive tumor radiosurgery for lung cancer
In this article
  1. Cancer related deaths in United States
  2. EDGE non-invasive tumor removal radiosurgery
  3. Compared with conventional surgery and conventional chemotherapy, the EDGE tumor non-invasive surgical removal system has the following advantages:
  4. Comparison of EDGE with gamma knife and wave knife:
  5. How CancerFax Helps

Cancer related deaths in United States

The American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer death rate in the United States has fallen by 22% from its peak in 1991 to the present, which means that 1.5 million cancer patients have avoided death. The report also predicted the incidence and mortality of cancer in the United States in 2015.

Lung cancer, rectal cancer, prostate cancer, and breast cancer are the most common cancer deaths, accounting for almost half of the total cancer mortality, and lung cancer accounts for 27%. For lung cancer, the mortality rate of male patients decreased by 36% from 1991 to 2011, and female patients decreased by 11%. Breast cancer mortality has declined by 35% from the peak to date, while prostate cancer and rectal cancer have decreased by 47%.

EDGE non-invasive tumor removal radiosurgery

Dr. Liao of the Henry Ford Hospital of the United States said that because American hospitals have the world’s most advanced technology and the most experts, the United States has been at the forefront of cancer treatment in the world. The introduction and use of the EDGE non-invasive tumor removal system has further improved the level of cancer treatment in the United States. And the five-year survival rate of cancer patients. The American Henry Ford Hospital Cancer Center is an American hospital with a team of 12 oncologists. Multidisciplinary experts work together to develop a personalized treatment plan for a patient to ensure that the treatment plan is comprehensive and effective.

The EDGE tumor non-invasive radiosurgery treatment system is a cancer treatment system approved by the US FDA in 2014. It is by far the most effective tumor radiosurgery system. It is difficult to perform routine surgery on tumors such as head tumors, lung cancer, spinal tumors, liver cancer and other solid tumors. It has a treatment effect that is difficult to achieve with conventional surgery and radiotherapy equipment, and is the best choice for cancer patients to remove tumor lesions so far.

Compared with conventional surgery and conventional chemotherapy, the EDGE tumor non-invasive surgical removal system has the following advantages:

  1. Non-invasive: without any incision, the patient does not need to undergo huge trauma of surgery;
  2. Short treatment time: about 10 minutes each treatment time, does not affect the patient’s quality of life;
  3. Less treatment times: 1-5 times, once a day, without hospitalization;
  4. High efficiency: Up to 5 tumors can be removed at the same time, and the tumor can be removed up to 5-175px, which is suitable for the removal of lesions in almost all patients with solid tumors;
  5. Thoroughly: track and lock the escaped tumor and clear it every 10 milliseconds, completely eliminate the tumor cells;
  6. High-intensity precision treatment: high-energy, 0.2-millimeter-level precision eliminates tumor cells, and almost no damage to surrounding important organs and tissues;
  7. Convenience: no anesthesia and no hospitalization;
  8. There are almost no side effects: the patient has no side effects of routine surgery and radiotherapy.

Comparison of EDGE with gamma knife and wave knife:

  1. Higher treatment intensity: EDGE radiation treatment intensity is more than 6 times that of gamma knife and wave knife, eliminating tumor cells more thoroughly.
  2. The treatment effect is better: 0.2 mm precision, dynamic and real-time tracking of tumor cells, the treatment effect is far better than the gamma knife and the wave knife.
  3. More tumor foci can be removed at a time: EDGE can remove up to 5 tumor foci at a time, and the treatment efficiency is higher, while gamma knife and wave knife can only remove one tumor foci at a time.
  4. Shorter time: EDGE resection of multiple brain metastases only takes about 10 minutes, while other radiation treatments such as gamma knife or wave knife take 1 to 5 hours.
  5. EDGE, almost no side effects of gamma knife and wave knife.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

Sai Sree

About Sai Sree

✓ Reviewed for medical accuracy by the CancerFax review panel.

Medical Disclaimer

This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.

Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.